Quadruple Marker Test is a prenatal screening test performed during the second trimester of pregnancy to assess the risk of chromosomal abnormalities and neural tube defects in the fetus. It measures four key markers: Alpha-fetoprotein (AFP), Human Chorionic Gonadotropin (hCG), Unconjugated Estriol (uE3), and Inhibin A. This test helps identify conditions such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and spina bifida. It is an important tool for early risk assessment, guiding further diagnostic testing and counseling.
Fasting
Not Required
Reporting Time
4–5 Days
Gender
Male/Female
Age Group
Pregnant Women
✔ Home collection available ✔ No hidden charges
Need help? Call 1800-123-4567
Kidney / Renal | Heart & Cardiac Health | Liver Test | Comprehensive Diabetes | Comprehensive Thyroid | Child & Adolescent Health | Women's Health | Men's Health | Cancer | Immunity & Allergy Test | Fever & Infection | Pancreas | Vitamins & Nutrition | Sexual Wellness/STDs | Bone & Joint Health | Hormonal | Urine & Stool Test | Infectious Diseases | Covid & Respiratory Health | Obesity & Metabolism | Dental & Oral Health | Eye & Vision Screening | Skin & Hair Health | Senior Citizen Checkups | Mental Health & Wellness | Autoimmune Disorder | Pregnancy & Fertility